Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 1 - 50 av 208 resultater
Tid
Selskap
Tittel
Sektor
Kategori
18 Dec 2024
07:30 CET
SENSORION
Sensorion Reports Data in the Audiogene Phase 1/2 Gene Therapy Clinical Trial
20103010 Biotechnology
New
18 Dec 2024
07:30 CET
SENSORION
Sensorion présente des données de l'essai clinique de Phase 1/2 de thérapie génique Audiogene
20103010 Biotechnology
New
03 Dec 2024
07:30 CET
SENSORION
Sensorion annonce sa participation à la 43ème conférence annuelle J.P. Morgan Healthcare Conference
20103010 Biotechnology
New
03 Dec 2024
07:30 CET
SENSORION
Sensorion to Present at the 43rd Annual J.P. Morgan Healthcare Conference
20103010 Biotechnology
New
06 Nov 2024
07:30 CET
SENSORION
Sensorion Announces Its Participation in Upcoming Investor Conferences to be Held in November 2024
20103010 Biotechnology
New
06 Nov 2024
07:30 CET
SENSORION
Sensorion annonce sa participation à plusieurs conférences investisseurs en novembre 2024
20103010 Biotechnology
New
17 Oct 2024
07:30 CEST
SENSORION
Sensorion annonce sa participation au 31ème Congrès annuel de la Société Européenne de Thérapie Génique et Cellulaire avec la présentation de plusieurs posters sur GJB2-GT
20103010 Biotechnology
New
17 Oct 2024
07:30 CEST
SENSORION
Sensorion Announces its Participation in the 31st Annual Congress of the European Society of Gene and Cell Therapy and the Presentation of Several Posters on GJB2-GT
20103010 Biotechnology
New
26 Sep 2024
07:30 CEST
SENSORION
Sensorion Announces Webconference for Retail Shareholders on October 10, 2024
20103010 Biotechnology
New
26 Sep 2024
07:30 CEST
SENSORION
Sensorion animera une webconférence dédiée aux actionnaires individuels le 10 octobre 2024
20103010 Biotechnology
New
23 Sep 2024
07:31 CEST
SENSORION
Sensorion Announces the Availability of its Half Year 2024 Report
20103010 Biotechnology
New
23 Sep 2024
07:31 CEST
SENSORION
Sensorion annonce la mise à disposition de son Rapport du 1er semestre 2024
20103010 Biotechnology
New
23 Sep 2024
07:30 CEST
SENSORION
Sensorion annonce de nouveaux résultats cliniques positifs présentés lors du Congrès Mondial d'Audiologie
20103010 Biotechnology
New
23 Sep 2024
07:30 CEST
SENSORION
Sensorion Reports New Positive Clinical Results Presented at the World Congress of Audiology
20103010 Biotechnology
New
20 Sep 2024
07:30 CEST
SENSORION
Sensorion annonce de nouvelles données cliniques positives relatives à ses programmes de thérapie génique et de petite molécule lors du Congrès Mondial d'Audiologie à Paris
20103010 Biotechnology
New
20 Sep 2024
07:30 CEST
SENSORION
Sensorion Announces New Positive Clinical Data Across its Gene Therapy and Small Molecule Programs at the World Congress of Audiology in Paris
20103010 Biotechnology
New
18 Sep 2024
07:30 CEST
SENSORION
Sensorion Reports 2024 First Half Results and Highlights Recent Updates
20103010 Biotechnology
Sales
18 Sep 2024
07:30 CEST
SENSORION
Sensorion publie ses résultats du premier semestre 2024 et fait le point sur ses activités
20103010 Biotechnology
Sales
12 Sep 2024
07:30 CEST
SENSORION
Sensorion annonce sa participation à la 59ème conférence annuelle Inner Ear Biology Workshopconsacrée à la biologie de l’oreille interne
20103010 Biotechnology
New
12 Sep 2024
07:30 CEST
SENSORION
Sensorion Announces Its Participation in the 59th Annual Inner Ear Biology Workshop
20103010 Biotechnology
New
02 Sep 2024
07:30 CEST
SENSORION
Sensorion Announces its Participation in the World Congress of Audiology in September 2024 in Paris and will Lead a Symposium on Medical Advances in the Field of Hearing Loss
20103010 Biotechnology
New
02 Sep 2024
07:30 CEST
SENSORION
Sensorion annonce sa participation auCongrès Mondial d’Audiologie en septembre 2024 à Paris et animera un symposium sur les avancées médicales dans le domaine de la perte auditive
20103010 Biotechnology
New
05 Aug 2024
07:30 CEST
SENSORION
Sensorion Announces its Participation in Stifel's Biotech Summer Summit
20103010 Biotechnology
New
05 Aug 2024
07:30 CEST
SENSORION
Sensorion annonce sa participation à la conférence « Biotech Summer Summit 2024 » organisée par Stifel
20103010 Biotechnology
New
23 Jul 2024
07:30 CEST
SENSORION
Sensorion annonce une recommandation positive du Comité de Surveillance des Données de Sécurité (DSMB) concernant la poursuite de NOTOXIS, son essai clinique de Phase 2a du SENS-401 dans l'ototoxicité induite par le cisplatine
20103010 Biotechnology
New
23 Jul 2024
07:30 CEST
SENSORION
Sensorion Announces Positive Recommendation From the Data Safety Monitoring Board (DSMB) Regarding the Continuation of NOTOXIS, its Phase 2a Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity
20103010 Biotechnology
New
15 Jul 2024
07:30 CEST
SENSORION
Sensorion Announces New Positive Secondary Efficacy Endpoints Data From SENS-401 Phase 2a Clinical Trial For The Preservation Of Residual Hearing Loss
20103010 Biotechnology
New
15 Jul 2024
07:30 CEST
SENSORION
Sensorion annonce de nouvelles données positives concernant les critères secondaires d’efficacité de l’essai clinique de Phase 2a de SENS-401 dans la préservation de l’audition résiduelle
20103010 Biotechnology
New
27 Jun 2024
07:30 CEST
SENSORION
Sensorion annonce la nomination de Laurène Danon en tant que Directrice Financière
20103010 Biotechnology
Journal / appointments
27 Jun 2024
07:30 CEST
SENSORION
Sensorion Announces the Appointment of Laurene Danon as Chief Financial Officer
20103010 Biotechnology
Journal / appointments
20 Jun 2024
07:30 CEST
SENSORION
Sensorion annonce la présentation de résultats prometteurs du SENS-401 lors de la prochaine Conférence Internationale sur les Implants Cochléaires et autres Technologies Implantables
20103010 Biotechnology
Meetings / events
20 Jun 2024
07:30 CEST
SENSORION
Sensorion Announces Upcoming Presentation of Promising SENS-401 Results at the Next International Conference on Cochlear Implants and Other Implantable Technologies
20103010 Biotechnology
Meetings / events
30 May 2024
07:30 CEST
SENSORION
Sensorion Publishes Results of Combined Shareholders’ General Meeting Resolutions
20103010 Biotechnology
General meeting / Board Meeting
30 May 2024
07:30 CEST
SENSORION
Sensorion publie les résultats des votes de l’Assemblée générale mixte des actionnaires
20103010 Biotechnology
General meeting / Board Meeting
28 May 2024
07:30 CEST
SENSORION
Sensorion annonce sa participation à des conférences investisseurs qui se tiendront en juin 2024
20103010 Biotechnology
Meetings / events
28 May 2024
07:30 CEST
SENSORION
Sensorion Announces its Participation in Upcoming Investor Conferences in June 2024
20103010 Biotechnology
Meetings / events
07 May 2024
08:25 CEST
SENSORION
Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 29, 2024
20103010 Biotechnology
Meetings / events
07 May 2024
08:25 CEST
SENSORION
Sensorion met à disposition des documents préparatoires à l’Assemblée générale mixte du 29 mai 2024
20103010 Biotechnology
Meetings / events
26 Apr 2024
07:30 CEST
SENSORION
Sensorion annonce sa participation à la conférence annuelle de la Société Américaine de Thérapie Génique et Cellulaire (ASGCT)
20103010 Biotechnology
Meetings / events
26 Apr 2024
07:30 CEST
SENSORION
Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT) Annual Meeting
20103010 Biotechnology
Meetings / events
10 Apr 2024
07:30 CEST
SENSORION
Sensorion Announces its Participation in the Van Lanschot Kempen's Life Sciences Conference
20103010 Biotechnology
Meetings / events
10 Apr 2024
07:30 CEST
SENSORION
Sensorion annonce sa participation à la conférence Van Lanschot Kempen’s Life Sciences
20103010 Biotechnology
Meetings / events
08 Apr 2024
07:30 CEST
SENSORION
Sensorion Announces a €15 Million Financing, Extending Cash Runway Until the End of 2025
20103010 Biotechnology
New
08 Apr 2024
07:30 CEST
SENSORION
Sensorion annonce un financement de 15 millions d’euros, et étend son horizon de trésorerie jusqu’à la fin de l’année 2025
20103010 Biotechnology
New
21 Mar 2024
07:30 CET
SENSORION
Sensorion Announces the Availability of Its Letter to Shareholders
20103010 Biotechnology
New
21 Mar 2024
07:30 CET
SENSORION
Sensorion annonce la mise à disposition de la Lettre aux Actionnaires
20103010 Biotechnology
New
15 Mar 2024
07:30 CET
SENSORION
Sensorion annonce sa participation à la conférence annuelle Bioprocessing Summit Europe
20103010 Biotechnology
Meetings / events
15 Mar 2024
07:30 CET
SENSORION
Sensorion Announces its Participation in the Annual Bioprocessing Summit Europe
20103010 Biotechnology
Meetings / events
14 Mar 2024
07:35 CET
SENSORION
Sensorion Announces the Availability of its Financial Report for 2023
20103010 Biotechnology
New
14 Mar 2024
07:35 CET
SENSORION
Sensorion annonce la mise à disposition de son Rapport Financier Annuel 2023
20103010 Biotechnology
New
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
1
2
3
›
››
»
Last »
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Stock options
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
DSP
Education
Academy
Stocks Education
Option education
Our Indices
Educational videos
News & Insights
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva